To explore the potential role of CD157 signaling in AML cell survival in vitro, we used BM and peripheral blood samples from 19 newly-diagnosed AML patients (Supplementary Table S1) showing variable levels of CD157 expression (Supplementary Fig. S1). This evidence concerns the gene BST1 and acute myeloid leukemia.